Prism Research Selects OmniComm Systems' TrialOne Suite to Automate Phase I Clinic Operations
OmniComm Systems, Inc., a company in the EDC marketplace, today announced that its TrialOne® suite of applications has been chosen by Prism Research to automate their clinical trial operations and processes within their early phase clinic.
TrialOne® is a web-based, mobile, clinic automation solution designed specifically for early-phase research to facilitate recruitment, appointment scheduling, study building and design, screening, source data capture, sample tracking and reporting. TrialOne® offers time-based data entry and integration with bar-code scanners and printers as well as biomedical monitoring devices to automate data, sample collection and processing. Additionally, TrialOne’s import and export features provide integration with LIM systems for lab orders and results processing as well as full SAS export capability including support of SDTM domains.
“Traditionally, implementing solutions for Phase I clinics has been difficult, time-consuming and cost prohibitive,” said Stephen Johnson, President and COO of OmniComm. “Most offerings today do not work well for these fast-paced clinics who demand instantaneous and reliable solutions. In the past, clinics have had to resort to localized solutions and manage the IT infrastructure internally. Implementations took up to a year and were extremely complex and resource intensive. With our Software-as-a-Service approach, the entire process from kickoff to production for this implementation will be less than 6 months.”
OmniComm offers a turnkey, hosted solution and a Quick Start validation package that facilitates and expedites the entire implementation process. Clinics can centralize their installation in OmniComm’s world-class data center and back-up facilities without the costly infrastructure and overhead of additional staff and software upgrades.
Prism Clinical Research is a Phase I-IV, 52-bed, clinical trial site located in the heart of the Minneapolis / St. Paul metropolitan area that specializes in complex, phase I and phase IIA clinical trials. In addition to healthy volunteer studies, Prism Clinical Research possesses a diverse, volunteer database of numerous disease states.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
